FierceBiotech Apr 8, 2026 With $2B Novo deal in the books, Vivtex isn't 'limited to being just a drug delivery company': CEO
eLife Apr 8, 2026 Identification and comparison of orthologous cell types from primate embryoid bodies shows limits of marker gene transferability
Lonza News Apr 7, 2026 Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development - Manufacturing Chemist
PLoS Biology Mar 31, 2026 Evidence for genetically-based sperm discrimination in the vaginal tract of a primate species
Lonza News Mar 31, 2026 Torqur AG strengthens bimiralisib development through Lonza partnership - Drug Discovery News
Lonza News Mar 27, 2026 Lonza opens Media Development Lab in Singapore for cell culture media optimisation - BioSpectrum Asia
Lonza News Mar 27, 2026 Lonza opens Media Development Lab in Singapore for cell culture media optimisation - BioSpectrum Asia
Cytiva (Google News) Mar 26, 2026 Yoshindo Builds In-House Biosimilars Capacity With Cytiva Support - Citeline News & Insights
Cytiva (Google News) Mar 24, 2026 Cytiva and Yoshindo advance domestic biosimilar manufacturing in Japan - BioSpectrum Asia
Cytiva (Google News) Mar 24, 2026 Cytiva and Yoshindo advance domestic biosimilar manufacturing in Japan - BioSpectrum Asia
Cytiva (Google News) Mar 24, 2026 Cytiva and Yoshindo advance domestic biosimilar manufacturing in Japan - BioSpectrum Asia
Cytiva (Google News) Mar 23, 2026 Yoshindo Strengthens Plans to Establish Biosimilar Manufacturing Capabilities in Japan with Cytiva Contract - Pearce IP
Thermo Fisher Mar 17, 2026 Thermo Fisher Scientific (TMO) Surged on Investors’ Optimism - Insider Monkey